Literature DB >> 25716179

The role of IL-17 in CNS diseases.

Ari Waisman1, Judith Hauptmann, Tommy Regen.   

Abstract

Cytokines of the IL-17 family are uniquely placed on the border between immune cells and tissue. Although IL-17 was originally found to induce the activation and mobilization of neutrophils to sites of inflammation, its tissue-specific function is not yet fully understood. The best-studied IL-17 family members, IL-17A and IL-17F, are both typically produced by immune cells such as Th17, γδ T cells and innate lymphoid cells group 3. However, the cells that respond to these cytokines are mostly found in inflamed tissue. As seen in psoriatic skin lesions or in joints of rheumatoid arthritis patients, high levels of IL-17 have been detected in the central nervous system (CNS) during inflammatory responses. Here, we provide a general review of the molecular function of IL-17 and its role in the CNS in particular. Of the different inflammatory conditions of the CNS, we found multiple sclerosis (MS) to be the one most associated with the presence of Th17 cells and IL-17. In particular, many studies using the murine model for MS, experimental autoimmune encephalomyelitis, found a clear association of Th17 and IL-17 with disease severity and progression. We summarize the recent advances made in correlating the presence of IL-17 with impaired blood-brain barrier integrity as well as the activation of astrocytes and microglia and the consequences for disease progression. There is also evidence that IL-17 plays a pathogenic role in the post-ischemic phase of stroke as well as its experimental model. We review the limited but promising data on the sources of post-stroke IL-17 production and its effects on CNS-resident target cells. In addition to MS and stroke, there is also evidence linking high levels of IL-17 to depression, as a frequent comorbidity of several inflammatory diseases, as well as to different types of infections of the CNS. The evidence we supply here suggests that inhibiting the function of the IL-17 cytokine family could have a beneficial effect on pathogenic conditions in the CNS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25716179     DOI: 10.1007/s00401-015-1402-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  92 in total

Review 1.  Control of autoimmune CNS inflammation by astrocytes.

Authors:  Veit Rothhammer; Francisco J Quintana
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

2.  Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma.

Authors:  Marjannie Eloi Akintunde; Melissa Rose; Paula Krakowiak; Luke Heuer; Paul Ashwood; Robin Hansen; Irva Hertz-Picciotto; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2015-07-11       Impact factor: 3.478

3.  Expression of IL-17F is associated with non-pathogenic Th17 cells.

Authors:  Florian Wanke; Yilang Tang; Konrad Gronke; Sabrina Klebow; Sonja Moos; Judith Hauptmann; Arthi Shanmugavadivu; Tommy Regen; Ilgiz A Mufazalov; Lauren A Gabriel; Sonja Reißig; Andreas Diefenbach; Florian C Kurschus; Ari Waisman
Journal:  J Mol Med (Berl)       Date:  2018-06-29       Impact factor: 4.599

4.  Neurocognitive Impairment as One Facet of Cancer-Related Sickness Behavior Symptoms.

Authors:  Carissa A Low; Pawel Kalinski; Dana H Bovbjerg
Journal:  J Natl Cancer Inst       Date:  2015-06-22       Impact factor: 13.506

Review 5.  Cytokine networks in neuroinflammation.

Authors:  Burkhard Becher; Sabine Spath; Joan Goverman
Journal:  Nat Rev Immunol       Date:  2016-12-05       Impact factor: 53.106

Review 6.  The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders.

Authors:  Lauren M Osborne; Amitoj Brar; Sabra L Klein
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

Review 7.  Chorioamnionitis, IL-17A, and fetal origins of neurologic disease.

Authors:  Shelley M Lawrence; James L Wynn
Journal:  Am J Reprod Immunol       Date:  2017-12-22       Impact factor: 3.886

8.  Protein kinase CK2 governs the molecular decision between encephalitogenic TH17 cell and Treg cell development.

Authors:  Alexander Ulges; Esther J Witsch; Gautam Pramanik; Matthias Klein; Katharina Birkner; Ulrike Bühler; Beatrice Wasser; Felix Luessi; Natascha Stergiou; Sarah Dietzen; Till-Julius Brühl; Toszka Bohn; Georg Bündgen; Horst Kunz; Ari Waisman; Hansjörg Schild; Edgar Schmitt; Frauke Zipp; Tobias Bopp
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-23       Impact factor: 11.205

Review 9.  Circulating immune cells in multiple sclerosis.

Authors:  A P Jones; A G Kermode; R M Lucas; W M Carroll; D Nolan; P H Hart
Journal:  Clin Exp Immunol       Date:  2016-11-02       Impact factor: 4.330

10.  Microarray expression profiling identifies genes, including cytokines, and biofunctions, as diapedesis, associated with a brain metastasis from a papillary thyroid carcinoma.

Authors:  Hans-Juergen Schulten; Deema Hussein; Fatima Al-Adwani; Sajjad Karim; Jaudah Al-Maghrabi; Mona Al-Sharif; Awatif Jamal; Sherin Bakhashab; Jolanta Weaver; Fahad Al-Ghamdi; Saleh S Baeesa; Mohammed Bangash; Adeel Chaudhary; Mohammed Al-Qahtani
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.